Machine Learning for Postoperative Continuous Recovery Scores of Oncology Patients in Perioperative Care with Data from Wearables

Sensors (Basel). 2023 May 2;23(9):4455. doi: 10.3390/s23094455.

Abstract

Assessing post-operative recovery is a significant component of perioperative care, since this assessment might facilitate detecting complications and determining an appropriate discharge date. However, recovery is difficult to assess and challenging to predict, as no universally accepted definition exists. Current solutions often contain a high level of subjectivity, measure recovery only at one moment in time, and only investigate recovery until the discharge moment. For these reasons, this research aims to create a model that predicts continuous recovery scores in perioperative care in the hospital and at home for objective decision making. This regression model utilized vital signs and activity metrics measured using wearable sensors and the XGBoost algorithm for training. The proposed model described continuous recovery profiles, obtained a high predictive performance, and provided outcomes that are interpretable due to the low number of features in the final model. Moreover, activity features, the circadian rhythm of the heart, and heart rate recovery showed the highest feature importance in the recovery model. Patients could be identified with fast and slow recovery trajectories by comparing patient-specific predicted profiles to the average fast- and slow-recovering populations. This identification may facilitate determining appropriate discharge dates, detecting complications, preventing readmission, and planning physical therapy. Hence, the model can provide an automatic and objective decision support tool.

Keywords: clinical prediction; hospital discharge; machine learning; monitoring; oncology; physical activity; post-operative recovery; vital signs; wearable sensors.

MeSH terms

  • Algorithms
  • Humans
  • Machine Learning
  • Neoplasms*
  • Perioperative Care
  • Wearable Electronic Devices*

Grants and funding

The TRICA trial was partly financed by a grant from the Rijksdienst voor Ondernemend Nederland (grant no. RVO ITEA 161006).